Cargando…

Eosinophils, beyond IL-5

Detalles Bibliográficos
Autores principales:	Esnault, Stephane, Johansson, Mats W, Mathur, Sameer K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8534157/ https://www.ncbi.nlm.nih.gov/pubmed/34685594 http://dx.doi.org/10.3390/cells10102615

Ejemplares similares

Comparison of IL-33 and IL-5 family mediated activation of human eosinophils
por: Angulo, Evelyn L., et al.
Publicado: (2019)

Platelet association with leukocytes in active eosinophilic esophagitis
por: Bartig, Kelly A., et al.
Publicado: (2021)

Autophagy Protects against Eosinophil Cytolysis and Release of DNA
por: Esnault, Stephane, et al.
Publicado: (2022)

Cholesterol Selectively Regulates IL-5 Induced Mitogen Activated Protein Kinase Signaling in Human Eosinophils
por: Burnham, Mandy E., et al.
Publicado: (2014)

Control of cytokine-driven eosinophil migratory behavior by TGF-beta-induced protein (TGFBI) and periostin
por: Barretto, Karina T., et al.
Publicado: (2018)

Protein Translation and Signaling in Human Eosinophils
por: Esnault, Stephane, et al.
Publicado: (2017)

Matrix Metalloproteinase-9-Dependent Release of IL-1β by Human Eosinophils
por: Esnault, Stephane, et al.
Publicado: (2019)

Identification of Genes Expressed by Human Airway Eosinophils after an In Vivo Allergen Challenge
por: Esnault, Stephane, et al.
Publicado: (2013)

Human eosinophil activin A synthesis and mRNA stabilization are induced by the combination of IL-3 plus TNF
por: Kelly, Elizabeth A., et al.
Publicado: (2016)

Beyond Il-5: Metabolic Reprogramming and Stromal Support Are Prerequisite for Generation and Survival of Long-Lived Eosinophil
por: Coden, Mackenzie E., et al.
Publicado: (2021)

Eosinophil Activation Status in Separate Compartments and Association with Asthma
por: Johansson, Mats W.
Publicado: (2017)

Open access and beyond
por: Mathur, Shawn, et al.
Publicado: (2006)

An open microfluidic coculture model of fibroblasts and eosinophils to investigate mechanisms of airway inflammation
por: Zeng, Yuting, et al.
Publicado: (2022)

Treating Acute Severe Eosinophilic Asthma with IL-5 Inhibitors in ICU
por: Barbarot, Nicolas, et al.
Publicado: (2022)

IL-3 and TNFα increase Thymic Stromal Lymphopoietin Receptor (TSLPR) expression on eosinophils and enhance TSLP-stimulated degranulation
por: Cook, Ellen B, et al.
Publicado: (2012)

Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor
Publicado: (1988)

Integrin Activation States and Eosinophil Recruitment in Asthma
por: Johansson, Mats W., et al.
Publicado: (2013)

Safety of Eosinophil-Depleting Therapy for Severe, Eosinophilic Asthma: Focus on Benralizumab
por: Jackson, David J., et al.
Publicado: (2020)

Editorial: Pathogenic Advances and Therapeutic Perspectives for Eosinophilic Inflammation
por: Roufosse, Florence E., et al.
Publicado: (2018)

Mouse resident lung eosinophils are dependent on IL‐5
por: Dolitzky, Avishay, et al.
Publicado: (2022)

Targeting the IL-5 pathway in eosinophilic asthma: a comparison of mepolizumab to benralizumab in the reduction of peripheral eosinophil counts
por: Ghassemian, Arian, et al.
Publicado: (2021)

Effects of prednisolone on eosinophils, IL-5, eosinophil cationic protein, EG2+ eosinophils, and nitric oxide metabolites in the sputum of patients with exacerbated asthma.
por: Jang, A. S., et al.
Publicado: (2000)

Update on eosinophilic gastrointestinal disease beyond eosinophilic esophagitis in children
por: Yang, Hye Ran
Publicado: (2023)

IL-5 and IL-6 are increased in the frontal recess of eosinophilic chronic rhinosinusitis patients
por: Kubota, Kazunori, et al.
Publicado: (2017)

Switch from IL-5 to IL-5-Receptor α Antibody Treatment in Severe Eosinophilic Asthma
por: Drick, Nora, et al.
Publicado: (2020)

Treatment with interleukin (IL)-5/IL-5 receptor antibodies in patients with severe eosinophilic asthma and COPD
por: Drick, Nora, et al.
Publicado: (2022)

The peptidyl-prolyl isomerase Pin1 facilitates cytokine-induced survival of eosinophils by suppressing Bax activation
por: Shen, Zhong-Jian, et al.
Publicado: (2009)

Combining Biologics Targeting Eosinophils (IL-5/IL-5R), IgE, and IL-4/IL-13 in Allergic and Inflammatory Diseases
por: Pitlick, Mitchell M., et al.
Publicado: (2022)

Targeting eosinophils: severe asthma and beyond
por: Caminati, Marco, et al.
Publicado: (2019)

Ratios of Four STAT3 Splice Variants in Human Eosinophils and Diffuse Large B Cell Lymphoma Cells
por: Turton, Keren B., et al.
Publicado: (2015)

Pin1 Regulates IL-5 Induced Eosinophil Polarization and Migration
por: Shen, Zhong-Jian, et al.
Publicado: (2021)

EOSINOPHILS AND IL-5 RECEPTOR IN COVID-19 POSTMORTEM LUNG TISSUE
por: MCCRAE, CHRISTOPHER, et al.
Publicado: (2021)

Treatment Challenges in Severe Eosinophilic Asthma: Differential Response to Anti-IL-5 and Anti-IL-5R Therapy
por: Bakakos, Agamemnon, et al.
Publicado: (2021)

Eosinophilic Infiltration in Korea: Idiopathic?
por: Lim, Jae Hoon, et al.
Publicado: (2006)

Is determining nasal eosinophil count and nasal eosinophil peroxidase concentration clinically useful in children with rhinits?
por: Choi, Bong Seok
Publicado: (2019)

Schistosoma mansoni egg-induced early IL-4 production is dependent upon IL-5 and eosinophils
Publicado: (1996)

Anti-IL5 therapy for asthma and beyond
por: Mukherjee, Manali, et al.
Publicado: (2014)

Anti-Interleukin 5 (IL-5) and IL-5Ra Biological Drugs: Efficacy, Safety, and Future Perspectives in Severe Eosinophilic Asthma
por: Bagnasco, Diego, et al.
Publicado: (2017)

Seeing Is Believing: Extravascular Platelet Recruitment in Asthma and Allergic Inflammation
por: Johansson, Mats W.
Publicado: (2021)

Susceptibility to L. sigmodontis infection is highest in animals lacking IL-4R/IL-5 compared to single knockouts of IL-4R, IL-5 or eosinophils
por: Frohberger, Stefan J., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9gf3pdlrdtcp3ed9trmeek4n6g